This study aimed to explore the impact of gestational diabetes mellitus (GDM) on the results of newborn hearing screening (NHS).
GDM increases annually in China and across the world. The authors completed a retrospective analysis of 666 women who gave birth between August 2017 and May 2018. Sixty-nine of the women had GDM and were assigned to Group 1, while 597 women were assigned as controls. Patients were between the ages of 20–44 years with an average gestation of 37–42 weeks.
Otoacoustic emissions (OAE) screening was completed on all newborns. If the initial screening was a “refer,” the screening was repeated two to three times. All babies who did not pass after more than one screening were referred for a diagnostic evaluation.
Comparisons of abnormal hearing screening between the groups were significantly different. In Group 1, the mothers with GDM, the refer rate was approximately 4.5 percent while in Group 2 (mothers without GDM), the refer rate was approximately 1.7 percent.
The authors conclude that that GDM has an impact on the hearing screening results of newborns and encourage physicians and other caretakers of pregnant women with GDM to ensure appropriate screening and follow up related to hearing.
Reference:
Zhou HZ, Yu K, Ding H, et al. (2021) A clinical study on gestational diabetes mellitus and the hearing of newborns. Diabetes Metab Syndr Obes 14:2879–2882.
Related Posts
World Alzheimer’s Month: Correlations with Hearing Loss and Cognitive Decline
Designated by Alzheimer’s Disease International (ADI), World Alzheimer’s Month occurs each September and is dedicated to raising awareness of and challenges with the stigmas associated with Alzheimer’s and dementia. Public awareness events are a time for individuals, organizations, and communities to share the message and lend support to care-givers, professionals, and individuals with Alzheimer’s. Recent…
The National Health Service Approves Test to Preserve the Hearing of Newborns
The National Health Service (NHS) is a conglomerate name for the publicly funded health-care system of the United Kingdom (England, Scotland, and Wales). Gentamicin is the first-choice antibiotic if a newborn develops a serious bacterial infection. According to the University of Manchester, approximately 90,000 babies a year in the United Kingdom alone are treated with…
Artificial Intelligence vs. Hearing Loss
Artificial intelligence (AI) is being used in so many facets of our existence. It is disrupting the status quo and challenging previously held beliefs and systems. From the looks of it, AI’s application in the hearing health-care arena is present and growing. AI use in hearing aids, in particular, is garnering attention outside the field….